TCM
BRLI

Tanaka Capital Management’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Tanaka Capital Management’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-46,830
Closed -$1.93M – 61
2015
Q2 		$1.93M Hold
46,830
– – 4.79% 5
2015
Q1 		$1.65M Buy
46,830
+245
+0.5% +$8.29K 4.56% 6
2014
Q4 		$1.5M Sell
46,585
-666
-1% -$19.3K 4.45% 5
2014
Q3 		$1.33M Hold
47,251
– – 3.87% 8
2014
Q2 		$1.43M Sell
47,251
-1,492
-3% -$41.2K 3.77% 8
2014
Q1 		$1.35M Buy
48,743
+23,893
+96% +$625K 4.1% 9
2013
Q4 		$635K Buy
24,850
+264
+1% +$8.14K 1.87% 19
2013
Q3 		$735K Buy
24,586
+30
+0.1% +$834 2.53% 16
2013
Q2 		$706K Buy
+24,556
New +$677K 2.52% 17

Other funds holding BRLI

SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Tanaka Capital Management's BRLI Position: Q3 2015 in Review

Tanaka Capital Management sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 46,830 shares — an estimated $1.93M sold.

Tanaka Capital Management first reported a position in BRLI in Q2 2013 and held it in 9 quarters. The position peaked at $1.93M in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

  • Tanaka Capital Management reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
  • Tanaka Capital Management sold 46,830 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $1.93M.
  • Tanaka Capital Management first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 9 quarters.
  • Tanaka Capital Management's BIO-REFERENCE LABS INC-NEW- position peaked at $1.93M in Q2 2015.
  • 1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Tanaka Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.